A New Mutation in IDS Gene Causing Hunter Syndrome: A Case Report
- PMID: 32256517
- PMCID: PMC7093562
- DOI: 10.3389/fgene.2019.01383
A New Mutation in IDS Gene Causing Hunter Syndrome: A Case Report
Abstract
Rationale: Mucopolysaccharidosis type II (Hunter syndrome) is an X-linked multisystem disorder, caused by deficiency of the lysosomal enzyme iduronate-2-sulfatase (I2S). The clinical manifestations of this disease are severe skeletal deformities, airway obstruction, cardiomyopathy, and neurologic deterioration.
Patient: The patient was 5 years and 6 months boy, with developmental delay, hearing loss, hepatosplenomegaly, and skeletal dysplasia. He was diagnosed with mucopolysaccharidosis type II based on clinical manifestations, biochemical and genetic analysis.
Outcomes: The patient carries a new mutation (c.879-1210_1007-218del) in hemizygosis in the IDS gene, which was defined as pathogenic according to the 2015 American College of Medical Genetics and Genomics-Association for Molecular Pathology guidelines and as responsible for the mucopolysaccharidosis type II phenotype in the patient.
Keywords: Hunter syndrome; IDS; iduronate-2-sulfatase; inborn errors of metabolism; lisossomal storage disease; mucopolysaccharidosis type II.
Copyright © 2020 Gomes, Marins, Motta, Kyosen, Curiati, D’Almeida, Martins and Pesquero.
Figures




Similar articles
-
Detailed pedigree analyses and prenatal diagnosis for a family with mucopolysaccharidosis type II.BMC Med Genomics. 2021 Jun 30;14(1):175. doi: 10.1186/s12920-021-01027-5. BMC Med Genomics. 2021. PMID: 34193122 Free PMC article.
-
Case report: a rare case of Hunter syndrome (type II mucopolysaccharidosis) in a girl.BMC Med Genet. 2019 May 2;20(1):66. doi: 10.1186/s12881-019-0807-x. BMC Med Genet. 2019. PMID: 31046699 Free PMC article.
-
A 38.8 kb deletion mutation of the iduronate-2-sulfatase gene in a patient with Hunter syndrome.J Formos Med Assoc. 2005 Apr;104(4):273-5. J Formos Med Assoc. 2005. PMID: 15909065
-
Diagnosis and Management of Mucopolysaccharidosis Type II (Hunter Syndrome) in Poland.Biomedicines. 2023 Jun 8;11(6):1668. doi: 10.3390/biomedicines11061668. Biomedicines. 2023. PMID: 37371763 Free PMC article. Review.
-
A review of the clinical outcomes in idursulfase-treated and untreated Filipino patients with mucopolysaccharidosis type II: data from the local lysosomal storage disease registry.Orphanet J Rare Dis. 2021 Jul 21;16(1):323. doi: 10.1186/s13023-021-01875-5. Orphanet J Rare Dis. 2021. PMID: 34289859 Free PMC article. Review.
Cited by
-
Detailed pedigree analyses and prenatal diagnosis for a family with mucopolysaccharidosis type II.BMC Med Genomics. 2021 Jun 30;14(1):175. doi: 10.1186/s12920-021-01027-5. BMC Med Genomics. 2021. PMID: 34193122 Free PMC article.
References
-
- Amiñoso C., Vallespin E., Fernández L., Arrabal L. F., Desviat L. R., Pérez B., et al. (2013). Identification of the first deletion–insertion involving the complete structure of GAA gene and part of CCDC40 gene mediated by an Alu element. Genetics 519, 169–172. - PubMed
-
- Birot A. M., Bouton O., Froissart R., Maire I., Bozon D. (1996). IDS Gene-Pseudogene exchange responsible for an intragenic deletion in a hunter patient. Hum. Mutat. 8, 844–850. - PubMed
Publication types
LinkOut - more resources
Full Text Sources